Bowden, C L
Mintz, J
Tohen, M
Article History
Received: 21 April 2014
Revised: 2 December 2014
Accepted: 19 December 2014
First Online: 17 March 2015
Competing interests
: CLB has received research support from Elan and participated in a Data Monitoring Board for Takeda. JM declares no conflict of interest. MT was a full time employee at Lilly (1997–2008). He has received honoraria from, or consulted for, Abbott, AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline, Lilly, Johnson & Johnson, Otsuka, Merck, Sunovion, Forest, Geodon Richter Plc, Roche, Elan, Alkermes, Lundbeck, Teva, Pamlab, Wyeth and Wiley Publishing and his spouse was a full time employee at Lilly (1998–2013).